Semaglutide has been tested in several robust clinical development programs and outcome studies in cardiometabolic diseases, including type 2 diabetes, obesity, cardiovascular disease, heart failure, chronic kidney disease, liver disease and other related cardiometabolic diseases
For some, the nausea is mild and goes away after a few days or weeks
To see if you qualify for a medically supervised program that includes doctor consultations and personalized support, your next step is to complete our free assessment quiz
You may still prescribe compounded GLP-1 drugs in certain circumstances, but your prescription must clearly articulate a medically necessary and significant difference from the commercially available drug product
The medication activates your GLP-1 receptors gradually, creating appetite suppression and improved blood sugar control throughout the week